Join our newsletter
Get updated info, tips and news about breastfeeding, e-lactancia project and other initiatives from APILAM
Legitimation: Consent of the interested party
As a user and interested I inform you that the data you provide will be located on the servers of MailChimp (email marketing provider of APILAM) outside the EU in the USA. MailChimp is covered by the EU-US Privacy Shield agreement, whose information is available here, approved by the European Committee for Data Protection. See Mailchimp's privacy policy. (https://mailchimp.com/legal/privacy/).
The fact that you do not enter the personal data that appear on the form as mandatory may have the consequence that we can not meet your request.
You can exercise your rights of access, rectification, limitation and delete the data in apilam.es@gmail.com as well as the right to file a claim with a control authority.
You can consult the additional and detailed information on Data Protection on this website: http://e-lactancia.org, as well as consult our own privacy policy.
Disease caused by the Hepatitis E virus (HEV), fecal-oral and vertical transmission during childbirth. Worldwide distribution but endemic in Southeast Asian and Central Asian countries. Generally benign, except in the third trimester of pregnancy when it can present as fulminant and fatal hepatitis (Chaudhry 2015, WHO 2014, Fiore 2009, Ranger 2002).
Although anti-HEV antibodies and HEV RNA have been found in colostrum and milk (Rivero 2016, Chibber 2004), transmission through breastfeeding has not been documented. (Krain 2014).
Transmission occurs exclusively in newborns born to mothers with acute illness at the time of delivery, even if they are not breastfed.(Chibber 2004)
Hepatitis E does not contraindicate breastfeeding. (Chaudhry 2015, Maher 2013, Sookoian 2006, Chibber 2004, Kumar 2001).